---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-003547"
form_type: "8-K"
ticker: "NPCE"
cik: "0001528287"
company_name: "NeuroPace Inc"
filed_at: "2025-01-08T23:59:59+00:00"
generated_at: "2026-05-28T06:35:34.852897+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# NeuroPace Reports Preliminary 2024 Revenue Above Guidance and Appoints Scott Huennekens to Board

## Summary
- Preliminary unaudited Q4 2024 revenue expected $21.0M-$21.5M (17-19% growth vs Q4 2023), full year $79.4M-$79.9M (21-22% growth), above initial guidance of $73M-$77M.
- Cash and short-term investments as of Dec 31, 2024 expected $52.8M; shares outstanding 30,145,039.
- Scott Huennekens appointed to Board of Directors effective Jan 6, 2025; granted options for 15,507 shares at $11.93.
- NAUTILUS trial one-year follow-up on track for March 2025; data lock and analysis in Q2 2025.
- Management to present at J.P. Morgan Healthcare Conference Jan 15 and host Investor Day Jan 28 in NYC.

## SEC filing metadata
- accession: 0001193125-25-003547
- form_type: 8-K
- ticker: NPCE
- cik: 0001528287
- company_name: NeuroPace Inc
- filed_at: 2025-01-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 2.02, 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1528287/000119312525003547/0001193125-25-003547-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1528287/000119312525003547/d889166d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-003547
- JSON: https://secwatch.observer/filing/0001193125-25-003547.json
- Plain text: https://secwatch.observer/filing/0001193125-25-003547.txt

## Key facts
- Executive change
  Scott Huennekens was appointed as Director at NeuroPace Inc.
  - Action: appointed
  - Role: Director
  source text: appointed Scott Huennekens as a director to fill the newly created vacancy, effective as of January 6, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1528287/000119312525003547/0001193125-25-003547-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.